Torbeck to Probe Recall Data For Insights Into Root Causes
This article was originally published in The Gold Sheet
Executive Summary
FDA consultant to tease out root causes of previous recalls.
You may also be interested in...
How FDA and Industry Aim to Find and Eliminate Drug Recalls' Root Causes
Rooting out recalls: FDA to inspect for common causes of recalls identified in ongoing study. Findings on subpotency and B. cepacia shared. Consultant offers process for root cause analysis.
A Pandemic Template For Swift Approval? Veklury Stability Questions Deferred For Later Study
The US FDA shaved months from review of Gilead’s Veklury (remdesivir) for COVID-19 with post-approval commitments for multiple stability studies. The Pink Sheet takes a deep dive look at discussions within the agency and with the sponsor.
Existing Subscriber?
Sign in to continue reading.
Need a specific report? 1000+ reports available
Buy Reports
Need a specific report? 1000+ reports available
Buy Reports
New to Pink Sheet?
Start a free trial today!
Register for our free email digests:
Register for our free email digests: